NCT06023849

Brief Summary

To compare immediate post-placental intrauterine contraceptive device insertion versus conventional placement at 6 weeks interval (often referred to as delayed or interval insertion) as regard to:-

  1. 1.Patient satisfaction.
  2. 2.Expulsion rate.
  3. 3.Complications

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Sep 2023

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 6, 2023

Completed
26 days until next milestone

Study Start

First participant enrolled

September 1, 2023

Completed
4 days until next milestone

First Posted

Study publicly available on registry

September 5, 2023

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 30, 2024

Completed
2 days until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2024

Completed
Last Updated

September 5, 2023

Status Verified

September 1, 2023

Enrollment Period

12 months

First QC Date

August 6, 2023

Last Update Submit

September 1, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • 1-Patient satisfaction and complication.

    assessment of patient satisfaction using a questionnaire as follow: * Will you use the same method of contraception after the next delivery? * Will you recommend the same method to your fellows? * Are you happy or not with this procedure? give score from 1 to 10, 1 mean you are very unhappy while 10 mean you are very happy. * have you developed any complication?

    6 months

Study Arms (2)

PPIUD

ACTIVE COMPARATOR

trans cesarean IUD insertion immediately post placental

Device: IUD insertion

interval

ACTIVE COMPARATOR

IUD insertion 6 weeks interval post-partum

Device: IUD insertion

Interventions

Trans Caesarean Intra Uterine Contraceptive Device Insertion and Conventional Postpartum 6 Weeks Insertion

PPIUDinterval

Eligibility Criteria

Age18 Years - 40 Years
Sexfemale(Gender-based eligibility)
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Age: 18-40years.
  • Full term pregnancies delivered by cesarean section.
  • Desire to have intrauterine contraceptive device (Cu T) as a contraceptive option.
  • Agree to participate in the study.

You may not qualify if:

  • Allergy to copper.
  • Ante- or intra-partum hemorrhage.
  • Ruptured of membranes for more than 18 h prior to delivery or Chorioamnionitis.
  • Known uterine abnormalities e.g., Bicornuate/septate Uterus, uterine myoma.
  • History of ectopic pregnancy.
  • Desire for pregnancy within 1 year of delivery.
  • Intrapartum fever \>38 c.
  • Sever thrombocytopenia.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Faculty of Medicin

Asyut, Egypt

RECRUITING

Related Publications (1)

  • Hem E, Bordahl PE. Max Sanger - father of the modern caesarean section. Gynecol Obstet Invest. 2003;55(3):127-9. doi: 10.1159/000071524.

    PMID: 12865589BACKGROUND

Central Study Contacts

Ahmed osman, M.B.B.Ch

CONTACT

Selim Ahmed, Assistant Professor

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
doctor

Study Record Dates

First Submitted

August 6, 2023

First Posted

September 5, 2023

Study Start

September 1, 2023

Primary Completion

August 30, 2024

Study Completion

September 1, 2024

Last Updated

September 5, 2023

Record last verified: 2023-09

Locations